Bristol Myers' Opdivo extends survival in bladder cancer study

Malaysia News News

Bristol Myers' Opdivo extends survival in bladder cancer study
Malaysia Latest News,Malaysia Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 97%

Bristol Myers Squibb Co said on Tuesday its blockbuster cancer immunotherapy, Opdivo, in combination with chemotherapy improved survival in patients with a type of bladder cancer in a late-stage trial.

Boxes of Opdivo from Bristol Myers are seen at the Huntsman Cancer Institute at the University of Utah in Salt Lake City, Utah, U.S., July 22, 2022. REUTERS/George Frey/File Photosaid on Tuesday its blockbuster cancer immunotherapy, Opdivo, in combination with chemotherapy improved survival in patients with a type of bladder cancer in a late-stage trial.

Opdivo was being studied in patients with types of urothelial carcinoma, or bladder cancer, who are eligible for standard-of-care cisplatin-based chemotherapy. In 2017, the U.S. Food and Drug Administration approved the use of Opdivo to include the treatment of some types of bladder cancer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ex-Dallas County sheriff worker sentenced to 2-plus years for embezzling from inmate fundEx-Dallas County sheriff worker sentenced to 2-plus years for embezzling from inmate fundUmeka Treymane Myers, 50, pleaded guilty to theft from a program receiving federal funds in June 2022. In addition to her sentence of two years and nine...
Read more »

Uncertain Benefit of Regional Nodal Irradiation in Low-Risk BCUncertain Benefit of Regional Nodal Irradiation in Low-Risk BCRegional nodal irradiation following surgery did not improve invasive disease-free survival in patients with breastcancer at low risk for recurrence, raising questions about the role of RNI in this population. MedTwitter
Read more »

Why HPV Screenings Are a Must for Older WomenWhy HPV Screenings Are a Must for Older WomenWomen older than 65 years who underwent catch-up testing for cervical cancer were more likely to be diagnosed with the disease than were those who did not, a new study found.
Read more »

Survival reality show 'NCT Universe: LASTART' introduces trainees Kassho & Haruta | allkpopSurvival reality show 'NCT Universe: LASTART' has revealed its latest teasers!The teaser videos for SM Entertainment's upcoming survival real…
Read more »

Watch: SM’s New Survival Show “NCT Universe : LASTART” Introduces Trainees Riku And RyoWatch: SM’s New Survival Show “NCT Universe : LASTART” Introduces Trainees Riku And RyoWATCH: SM's New Survival Show 'NCT Universe : LASTART' Introduces Trainees Riku And Ryo
Read more »

Watch: SM’s Upcoming Survival Show “NCT Universe : LASTART” Introduces Trainees Kassho And HarutaWatch: SM’s Upcoming Survival Show “NCT Universe : LASTART” Introduces Trainees Kassho And HarutaWatch: SM's Upcoming Survival Show 'NCT Universe : LASTART' Introduces Trainees Kassho And Haruta
Read more »



Render Time: 2025-02-26 15:15:56